COVID-19 vaccine: Bharat Biotech seeks nod to conduct COVAXIN trials in Bangladesh
If allowed to go ahead, this would be the first trial of any coronavirus vaccine in Bangladesh and could give the densely-populated country of more than 160 million faster access to the shot for mass use
Reuters | January 21, 2021 | Updated 13:16 IST
The vaccine, developed with the Indian Council of Medical Research, was given the green light for restricted use in India this month without any efficacy data from a late-stage trial
India's Bharat Biotech has applied to conduct trials in Bangladesh for its coronavirus vaccine recently approved for emergency use at home, a senior official at Bangladesh's main medical research body told Reuters. If allowed to go ahead, this would be the first trial of any coronavirus vaccine in Bangladesh and could give the densely-populated country of more than 160 million faster access to the shot for mass use.